These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 35986867)

  • 21. Dose adjustment based on the plasma level measurement used anti-FXa chromogenic assay on the use of non-vitamin K antagonist oral anticoagulants (NOACs) improved the overall benefit of NOACs dosing in patients with atrial fibrillation: Authors' reply.
    Steffel J; Heidbüchel H
    Europace; 2021 Oct; 23(10):1686-1687. PubMed ID: 34549781
    [No Abstract]   [Full Text] [Related]  

  • 22. The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation.
    Beyer-Westendorf J; Fay M; Amara W
    TH Open; 2021 Jul; 5(3):e353-e362. PubMed ID: 34435170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and the EHRA Practical Guide.
    Capiau A; De Backer T; Grymonprez M; Lahousse L; Van Tongelen I; Mehuys E; Boussery K
    Int J Cardiol; 2021 Apr; 328():97-103. PubMed ID: 33279589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants.
    Camm AJ; Cools F; Virdone S; Bassand JP; Fitzmaurice DA; Arthur Fox KA; Goldhaber SZ; Goto S; Haas S; Mantovani LG; Kayani G; Grierson Turpie AG; Antoon Verheugt FW; Kakkar AK;
    J Am Coll Cardiol; 2020 Sep; 76(12):1425-1436. PubMed ID: 32943160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.
    Hindricks G; Potpara T; Dagres N; Arbelo E; Bax JJ; Blomström-Lundqvist C; Boriani G; Castella M; Dan GA; Dilaveris PE; Fauchier L; Filippatos G; Kalman JM; La Meir M; Lane DA; Lebeau JP; Lettino M; Lip GYH; Pinto FJ; Thomas GN; Valgimigli M; Van Gelder IC; Van Putte BP; Watkins CL;
    Eur Heart J; 2021 Feb; 42(5):373-498. PubMed ID: 32860505
    [No Abstract]   [Full Text] [Related]  

  • 26. Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation.
    Chan YH; Chao TF; Chen SW; Lee HF; Yeh YH; Huang YC; Chang SH; Kuo CT; Lip GYH; Chen SA
    Heart Rhythm; 2020 Dec; 17(12):2102-2110. PubMed ID: 32702416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Misdosing of Non-Vitamin K Antagonist Oral Anticoagulants in Primary Care.
    Cardoso CS; Sousa JA; Simões P; Silva B; Albuquerque A; Esperança A; Cibrão A; Correia A; Gonçalves J; Mortágua J; Almeida JE; Oliveira L; Garcia J; Duarte M; Loureiro M; Costa E Silva M; Fraga M; Lopes P; Brandão R; Miguel S; Queirós T; Santo G; Silva F; Sargento-Freitas J
    Clin Ther; 2020 Jun; 42(6):1132-1136.e1. PubMed ID: 32513496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of direct oral anticoagulant off-label doses on clinical outcomes of atrial fibrillation patients: A systematic review.
    Santos J; António N; Rocha M; Fortuna A
    Br J Clin Pharmacol; 2020 Mar; 86(3):533-547. PubMed ID: 31631392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK.
    García Rodríguez LA; Martín-Pérez M; Vora P; Roberts L; Balabanova Y; Brobert G; Fatoba S; Suzart-Woischnik K; Schaefer B; Ruigomez A
    BMJ Open; 2019 Sep; 9(9):e031341. PubMed ID: 31542760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
    January CT; Wann LS; Calkins H; Chen LY; Cigarroa JE; Cleveland JC; Ellinor PT; Ezekowitz MD; Field ME; Furie KL; Heidenreich PA; Murray KT; Shea JB; Tracy CM; Yancy CW
    J Am Coll Cardiol; 2019 Jul; 74(1):104-132. PubMed ID: 30703431
    [No Abstract]   [Full Text] [Related]  

  • 31. Appropriateness of DOAC Prescribing Before and During Hospital Admission and Analysis of Determinants for Inappropriate Prescribing.
    Moudallel S; Steurbaut S; Cornu P; Dupont A
    Front Pharmacol; 2018; 9():1220. PubMed ID: 30425641
    [No Abstract]   [Full Text] [Related]  

  • 32. Variability in Non-Vitamin K Antagonist Oral Anticoagulants Dose Adjustment in Atrial Fibrillation Patients With Renal Dysfunction: The Influence of Renal Function Estimation Formulae.
    Andrade JG; Hawkins NM; Fordyce CB; Deyell MW; Er L; Djurdjev O; Macle L; Virani SA; Levin A
    Can J Cardiol; 2018 Aug; 34(8):1010-1018. PubMed ID: 29980468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function : Post hoc analysis of a prospective cohort.
    Malavasi VL; Pettorelli D; Fantecchi E; Zoccali C; Laronga G; Trenti T; Lip GYH; Boriani G
    Intern Emerg Med; 2018 Oct; 13(7):1059-1067. PubMed ID: 29736630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
    Steffel J; Verhamme P; Potpara TS; Albaladejo P; Antz M; Desteghe L; Haeusler KG; Oldgren J; Reinecke H; Roldan-Schilling V; Rowell N; Sinnaeve P; Collins R; Camm AJ; Heidbüchel H;
    Eur Heart J; 2018 Apr; 39(16):1330-1393. PubMed ID: 29562325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry.
    Ruiz Ortiz M; Muñiz J; Raña Míguez P; Roldán I; Marín F; Asunción Esteve-Pastor M; Cequier A; Martínez-Sellés M; Bertomeu V; Anguita M;
    Europace; 2018 Oct; 20(10):1577-1583. PubMed ID: 29186393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
    Yao X; Shah ND; Sangaralingham LR; Gersh BJ; Noseworthy PA
    J Am Coll Cardiol; 2017 Jun; 69(23):2779-2790. PubMed ID: 28595692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry.
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli G; Reiffel J; Singer DE; Peterson ED; Piccini JP;
    J Am Coll Cardiol; 2016 Dec; 68(24):2597-2604. PubMed ID: 27978942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis.
    Steffel J; Giugliano RP; Braunwald E; Murphy SA; Mercuri M; Choi Y; Aylward P; White H; Zamorano JL; Antman EM; Ruff CT
    J Am Coll Cardiol; 2016 Sep; 68(11):1169-1178. PubMed ID: 27609678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.
    Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
    Europace; 2015 Oct; 17(10):1467-507. PubMed ID: 26324838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Edoxaban versus warfarin in patients with atrial fibrillation.
    Giugliano RP; Ruff CT; Braunwald E; Murphy SA; Wiviott SD; Halperin JL; Waldo AL; Ezekowitz MD; Weitz JI; Špinar J; Ruzyllo W; Ruda M; Koretsune Y; Betcher J; Shi M; Grip LT; Patel SP; Patel I; Hanyok JJ; Mercuri M; Antman EM;
    N Engl J Med; 2013 Nov; 369(22):2093-104. PubMed ID: 24251359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.